
Terry A Wallace
Examiner (ID: 15893, Phone: (571)272-2630 , Office: P/2916 )
| Most Active Art Unit | 2916 |
| Art Unit(s) | 2912, 2916, 2900, 2902 |
| Total Applications | 11456 |
| Issued Applications | 11361 |
| Pending Applications | 2 |
| Abandoned Applications | 91 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7172285
[patent_doc_number] => 20050203059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods and compositions for treatment of ischemia'
[patent_app_type] => utility
[patent_app_number] => 10/506570
[patent_app_country] => US
[patent_app_date] => 2003-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16383
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506570
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506570 | Methods and compositions for treatment of ischemia | Mar 2, 2003 | Abandoned |
Array
(
[id] => 6822091
[patent_doc_number] => 20030220252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analog'
[patent_app_type] => new
[patent_app_number] => 10/377213
[patent_app_country] => US
[patent_app_date] => 2003-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9226
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10377213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/377213 | Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analog | Feb 28, 2003 | Abandoned |
Array
(
[id] => 817197
[patent_doc_number] => 07411005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Compositions and methods for increasing milk production in animals'
[patent_app_type] => utility
[patent_app_number] => 10/366634
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6974
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/411/07411005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10366634
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/366634 | Compositions and methods for increasing milk production in animals | Feb 11, 2003 | Issued |
Array
(
[id] => 7207613
[patent_doc_number] => 20040087613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Prevention of adhesions with rapamycin'
[patent_app_type] => new
[patent_app_number] => 10/349904
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1380
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087613.pdf
[firstpage_image] =>[orig_patent_app_number] => 10349904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/349904 | Prevention of adhesions with rapamycin | Jan 22, 2003 | Abandoned |
Array
(
[id] => 6710570
[patent_doc_number] => 20030170319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/342044
[patent_app_country] => US
[patent_app_date] => 2003-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8466
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10342044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/342044 | Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer | Jan 12, 2003 | Issued |
Array
(
[id] => 944164
[patent_doc_number] => 06967218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-22
[patent_title] => 'Pravastatin pharmaceutical formulations and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 10/339487
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12760
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/967/06967218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339487 | Pravastatin pharmaceutical formulations and methods of their use | Jan 9, 2003 | Issued |
Array
(
[id] => 7208052
[patent_doc_number] => 20040087651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Monoterpene as a chemopreventive agent for regression of mammalian nervous system cell tumors, use of monoterpene for causing regression and inhibition of nervous system cell tumors, and method for administration of monoterpene perillyl alcohol'
[patent_app_type] => new
[patent_app_number] => 10/318385
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3431
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10318385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/318385 | Monoterpene as a chemopreventive agent for regression of mammalian nervous system cell tumors, use of monoterpene for causing regression and inhibition of nervous system cell tumors, and method for administration of monoterpene perillyl alcohol | Dec 12, 2002 | Abandoned |
Array
(
[id] => 6852092
[patent_doc_number] => 20030144295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Treatment for ischemic stroke'
[patent_app_type] => new
[patent_app_number] => 10/307918
[patent_app_country] => US
[patent_app_date] => 2002-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9601
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10307918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/307918 | Treatment for ischemic stroke | Dec 2, 2002 | Abandoned |
Array
(
[id] => 6818355
[patent_doc_number] => 20030069313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue'
[patent_app_type] => new
[patent_app_number] => 10/283573
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5426
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10283573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/283573 | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue | Oct 29, 2002 | Issued |
Array
(
[id] => 695529
[patent_doc_number] => 07071228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-04
[patent_title] => 'Method of treating musculoskeletal and connective tissue inflammations'
[patent_app_type] => utility
[patent_app_number] => 10/278706
[patent_app_country] => US
[patent_app_date] => 2002-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4176
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10278706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/278706 | Method of treating musculoskeletal and connective tissue inflammations | Oct 22, 2002 | Issued |
Array
(
[id] => 7122913
[patent_doc_number] => 20050014742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Use of inhibitors of the y2 receptor of neuropeptide y in the treatment of alcoholism'
[patent_app_type] => utility
[patent_app_number] => 10/492785
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5199
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492785 | Use of inhibitors of the y2 receptor of neuropeptide y in the treatment of alcoholism | Oct 17, 2002 | Abandoned |
Array
(
[id] => 6640087
[patent_doc_number] => 20030212085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Treatment of fibromyalgia and chronic fatigue syndrome'
[patent_app_type] => new
[patent_app_number] => 10/258203
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4444
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258203
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258203 | Treatment of fibromyalgia and chronic fatigue syndrome | Oct 17, 2002 | Abandoned |
Array
(
[id] => 6761981
[patent_doc_number] => 20030125343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound'
[patent_app_type] => new
[patent_app_number] => 10/169035
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17235
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169035
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169035 | Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound | Oct 6, 2002 | Abandoned |
Array
(
[id] => 7446435
[patent_doc_number] => 20040067255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Method of administering split doses of a vascular targeting agent'
[patent_app_type] => new
[patent_app_number] => 10/265820
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3958
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067255.pdf
[firstpage_image] =>[orig_patent_app_number] => 10265820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/265820 | Method of administering split doses of a vascular targeting agent | Oct 6, 2002 | Abandoned |
Array
(
[id] => 7270482
[patent_doc_number] => 20040059000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Therapeutic agents and corresponding treatments'
[patent_app_type] => new
[patent_app_number] => 10/251616
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7964
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20040059000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251616
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251616 | Therapeutic agents and corresponding treatments | Sep 19, 2002 | Issued |
Array
(
[id] => 6926604
[patent_doc_number] => 20050239861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Medicinal composition'
[patent_app_type] => utility
[patent_app_number] => 10/526780
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7871
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526780 | Medicinal composition | Sep 11, 2002 | Issued |
Array
(
[id] => 6669520
[patent_doc_number] => 20030114504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Compositions and methods for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/228544
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10911
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228544 | Compositions and methods for the treatment of cancer | Aug 26, 2002 | Abandoned |
Array
(
[id] => 6822223
[patent_doc_number] => 20030220384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia'
[patent_app_type] => new
[patent_app_number] => 10/226247
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7398
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220384.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226247 | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia | Aug 22, 2002 | Abandoned |
Array
(
[id] => 7034368
[patent_doc_number] => 20050032878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Oral pharmaceutical composition containing a combination pparalpha and a hmg-coa reductase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/486219
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3108
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486219
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486219 | Oral pharmaceutical composition containing a combination pparalpha and a hmg-coa reductase inhibitor | Aug 6, 2002 | Abandoned |
Array
(
[id] => 691123
[patent_doc_number] => 07074824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-11
[patent_title] => 'Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 10/343091
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15428
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343091 | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same | Jul 30, 2002 | Issued |